Stoeckemann K, Hegele-Hartung C, Chwalisz K. Effects of the progesterone antagonists onapristone (ZK 98 299) and ZK 136 799 on surgically induced endometriosis in intact rats. Hum Reprod 1995;10:3264–3271.
386.
Fuhrmann U, Hess Stummp H, Cleve A, et al. Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 2000;43:5010–5016.
387.
Slayden OD, Chwalisz K, Brenner RM. Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 2001;8:1562–1574.
388.
Brosens IA, Verleyen A, Cornillie FJ. The morphologic effect of short-term medical therapy of endometriosis. Am J Obstet Gynecol 1987;157:1215–1221.
389.
Fedele L, Bianchi S, Viezzoli T, et al. Gestrinone versus danazol in the treatment of endometriosis. Fertil Steril 1989;51:781–785.
390.
Wingfield M, Healy DL. Endometriosis: medical therapy. Baillieres Clin Obstet Gynecol 1993;7:813–838.
391.
Hornstein MD, Gleason RE, Barbieri RL. A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis. Fertil Steril 1990;53:237–241.
392.
Gestrinone Italian Study Group. Gestrinone versus a GnRHa for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Fertil Steril 1996;66:911– 919.
393.
Barbieri RL, Ryan KJ. Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol 1981;141:453–463.
394.
El-Roeiy A, Dmowski WP, Gleicher N, et al. Danazol but not gonadotropin-releasing hormone agonists suppresses autoantibodies in endometriosis. Fertil Steril 1988:50;864–871.
395.
Ota H, Maki M, Shidara Y, et al. Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol 1992;167:481–486.
396.
Hill JA, Haimovici F, Politch JA, et al. Effects of soluble products of activated macrophages (lymphokines and monokines) on human sperm motion parameters. Fertil Steril 1987;47:460–465.
397.
Mori H, Nakagawa M, Itoh N, et al. Danazol suppresses the production of interleukin-1b and tumor necrosis factor by human monocytes. Am J Reprod Immunol 1990;24:45–50.
398.